Our Recommendations
New Publications
- Global leprosy (Hansen disease) update, 2023: Elimination of leprosy disease is possible – Time to act! (2024)
- Global leprosy (Hansen disease) update, 2022: new paradigm – control to elimination (2023)
- Towards zero leprosy. Global leprosy (Hansen’s Disease) strategy 2021–2030 (2021)
- Leprosy Programme and Transmission Assessment - Tool accompanying the Technical guidance on interruption of transmission and elimination of leprosy (2023)
- Leprosy Programme and Transmission Assessment (2023)
Filter
43
Featured
Recommendations
3
New Publications
13
Language
Document type
No document type
35
Studies & Reports
3
Situation Updates
2
Strategic & Response Plan
2
Guidelines
1
Countries / Regions
Brazil
2
Kenya
1
Sierra Leone
1
Global
1
Germany
1
India
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
1
Policies
1
Guidelines
1
Leprosy
1
Leprosy
1
Toolboxes
Policies & Strategies
27
Prevention & Control
9
Epidemiology & Sitreps
4
Maps
3
ince the introduction of multidrug therapy (MDT), there has been significant progress in reducing the prevalence of leprosy and the occurrence of new cases. Global strategies have evolved with progress in reducing the disease burden. Encouraged by the decrease in the number of cases on treatment, th...
The Global Leprosy Strategy 2021–2030 “Towards zero leprosy” was developed through a broad consultative process with all major stakeholders during 2019 and 2020. Valuable inputs were provided by national leprosy programme managers, technical agencies, public health and leprosy experts, funding...
The Leprosy Programme and Transmission Assessment (LPTA) is an activity that is carried out by internal teams towards the end of Phase 1 (see Leprosy Elimination Framework in the Annex) when a subnational jurisdiction (typically second-tier) reaches the milestone for interruption of transmission, i....
The Leprosy Programme and Transmission Assessment (LPTA) is an activity that is carried out by internal teams towards the end of Phase 1 (see Leprosy Elimination Framework in the Annex) when a subnational jurisdiction (typically second-tier) reaches the milestone for interruption of transmission, i....
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
Weekly epidemiological record; Relevé épidémiologique hebdomadaire 10 SEPTEMBER 2021, 96th YEAR / 10 SEPTEMBRE 2021, 96e ANNÉE No 36, 2021, 96, 421–444
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution...
Epidemiologisches Bulletin, 25 Januar 2018/ No.4, 49-53
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
Weekly epidemiological record/Relevé épidémiologique hebdomadaire , 1ST SEPTEMBER 2017, 92th YEAR / no.35 (2017) 501-520
Accelerating towards a leprosy-free world
